- This event has passed.
Home » Events » The Mason Family 20for20 Challenge for 2021
Start: | 26/10/2021 @ 8:00 am |
End: | 24/12/2021 @ 5:00 pm |
Dave says in is JustGiving page:
We are doing this for Donna ?
MDS UK is a great charity that has been a massive support to my wife Donna since she was diagnosed with Myelodysplastic Syndrome (|MDS) a rare form of blood cancer 7 years ago. They fund research and provide support to all sufferers.
There are many different forms of MDS, but essentially they all affect your bone marrow’s ability to produce healthy blood cells. For Donna this means a very suppressed immune system which means the effectiveness of the covid vaccine is hugely reduced.
So living with Covid is a big challenge for us and has greatly affected how we live as a family and how little we can integrate with our friends and social/work/school settings. We consider ourselves lucky every day, but there are so many MDS sufferers out there struggling to to ‘live with covid’ when the risk of catching the virus could have such terrible impact for them.
So doing the 20for20 Challenge is our chance to challenge ourselves. We did this last year, and whilst it is not like a normal big physical event, it still tests you to engage in a new challenge every day no matter how you feel.
So, I hope you enjoy following our 20for20 journey and hope you might be able to donate to this amazing charity that is supporting so many people like Donna out there as they try and battle a disease made even worse by the threat of Covid.
Today, more than ever, we need generous people like you, to maintain our services to MDS patients and their families during Covid-19.
YOU ARE MAKING A DIFFERENCE!
PLEASE SUPPORT THE MASON FAMILY AND HELP US ASSIST MDS PATIENTS AND THEIR FAMILIES
£25 could help us towards printing and sending information to support MDS patients
£50 could help us run our helpline & patient meetings for emotional & practical support
£100 could help us fund our advocacy work to ensure new drugs are approved
£250 could help us towards funding research to improve MDS treatments